nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—Cytochrome P450 2C9 Inhibitors—Zafirlukast—asthma	0.448	1	CiPCiCtD
Regorafenib—NTRK1—asthma	0.167	1	CbGaD
Regorafenib—EPHX2—Zileuton—asthma	0.0837	0.358	CbGbCtD
Regorafenib—UGT1A9—Zileuton—asthma	0.0176	0.0754	CbGbCtD
Regorafenib—UGT1A1—Indacaterol—asthma	0.0174	0.0744	CbGbCtD
Regorafenib—ABCG2—Zafirlukast—asthma	0.00698	0.0299	CbGbCtD
Regorafenib—CYP2C8—Salmeterol—asthma	0.00474	0.0203	CbGbCtD
Regorafenib—CYP2C8—Mometasone—asthma	0.00474	0.0203	CbGbCtD
Regorafenib—ABCB1—Fluticasone furoate—asthma	0.00424	0.0181	CbGbCtD
Regorafenib—CYP2C8—Zafirlukast—asthma	0.00372	0.0159	CbGbCtD
Regorafenib—ABCB1—Indacaterol—asthma	0.00345	0.0148	CbGbCtD
Regorafenib—CYP2C19—Zafirlukast—asthma	0.00312	0.0133	CbGbCtD
Regorafenib—CYP2C19—Formoterol—asthma	0.00301	0.0129	CbGbCtD
Regorafenib—CYP2C19—Arformoterol—asthma	0.00301	0.0129	CbGbCtD
Regorafenib—CYP2C9—Zileuton—asthma	0.00295	0.0126	CbGbCtD
Regorafenib—CYP2C8—Theophylline—asthma	0.00287	0.0123	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—asthma	0.00284	0.0122	CbGbCtD
Regorafenib—CYP2C8—Loratadine—asthma	0.00272	0.0116	CbGbCtD
Regorafenib—CYP2C8—Montelukast—asthma	0.00272	0.0116	CbGbCtD
Regorafenib—CYP2C9—Zafirlukast—asthma	0.0026	0.0111	CbGbCtD
Regorafenib—CYP3A4—Fluticasone furoate—asthma	0.00254	0.0108	CbGbCtD
Regorafenib—CYP2C9—Arformoterol—asthma	0.00251	0.0107	CbGbCtD
Regorafenib—CYP2C9—Formoterol—asthma	0.00251	0.0107	CbGbCtD
Regorafenib—CYP2C19—Loratadine—asthma	0.00228	0.00977	CbGbCtD
Regorafenib—CYP3A4—Budesonide—asthma	0.00226	0.00967	CbGbCtD
Regorafenib—CYP3A4—Ciclesonide—asthma	0.00207	0.00884	CbGbCtD
Regorafenib—CYP3A4—Indacaterol—asthma	0.00207	0.00884	CbGbCtD
Regorafenib—CYP2C9—Theophylline—asthma	0.002	0.00857	CbGbCtD
Regorafenib—CYP3A4—Salbutamol—asthma	0.00192	0.00822	CbGbCtD
Regorafenib—CYP3A4—Salmeterol—asthma	0.00192	0.00822	CbGbCtD
Regorafenib—CYP3A4—Flunisolide—asthma	0.00192	0.00822	CbGbCtD
Regorafenib—CYP2C9—Loratadine—asthma	0.0019	0.00812	CbGbCtD
Regorafenib—CYP2C9—Montelukast—asthma	0.0019	0.00812	CbGbCtD
Regorafenib—ABCB1—Loratadine—asthma	0.00184	0.00788	CbGbCtD
Regorafenib—ABCG2—Dexamethasone—asthma	0.00177	0.00756	CbGbCtD
Regorafenib—CYP3A4—Ipratropium bromide—asthma	0.00171	0.00733	CbGbCtD
Regorafenib—CYP3A4—Zileuton—asthma	0.00171	0.00733	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—asthma	0.00169	0.00721	CbGbCtD
Regorafenib—CYP3A4—Fluticasone Propionate—asthma	0.00164	0.00699	CbGbCtD
Regorafenib—RET—autonomic nervous system—asthma	0.00155	0.0477	CbGeAlD
Regorafenib—CYP2C8—Hydrocortisone—asthma	0.00151	0.00648	CbGbCtD
Regorafenib—CYP3A4—Zafirlukast—asthma	0.00151	0.00645	CbGbCtD
Regorafenib—CYP3A4—Tiotropium—asthma	0.0013	0.00555	CbGbCtD
Regorafenib—CYP2C19—Prednisone—asthma	0.00127	0.00541	CbGbCtD
Regorafenib—CYP2B6—Dexamethasone—asthma	0.00124	0.00532	CbGbCtD
Regorafenib—CYP3A4—Aminophylline—asthma	0.00124	0.0053	CbGbCtD
Regorafenib—CYP3A4—Theophylline—asthma	0.00117	0.00498	CbGbCtD
Regorafenib—CYP3A4—Loratadine—asthma	0.0011	0.00472	CbGbCtD
Regorafenib—CYP3A4—Montelukast—asthma	0.0011	0.00472	CbGbCtD
Regorafenib—ABCB1—Betamethasone—asthma	0.0011	0.00469	CbGbCtD
Regorafenib—ABCB1—Prednisolone—asthma	0.00108	0.00462	CbGbCtD
Regorafenib—ABCB1—Hydrocortisone—asthma	0.00103	0.00438	CbGbCtD
Regorafenib—ABCB1—Prednisone—asthma	0.00102	0.00437	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—asthma	0.00101	0.00432	CbGbCtD
Regorafenib—CYP2C8—Dexamethasone—asthma	0.000942	0.00403	CbGbCtD
Regorafenib—CYP2C19—Dexamethasone—asthma	0.00079	0.00338	CbGbCtD
Regorafenib—CYP3A4—Triamcinolone—asthma	0.000766	0.00327	CbGbCtD
Regorafenib—DDR2—respiratory system—asthma	0.000744	0.0228	CbGeAlD
Regorafenib—FGFR2—exocrine gland—asthma	0.00073	0.0224	CbGeAlD
Regorafenib—CYP2C9—Dexamethasone—asthma	0.000657	0.00281	CbGbCtD
Regorafenib—CYP3A4—Betamethasone—asthma	0.000657	0.00281	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—asthma	0.000648	0.00277	CbGbCtD
Regorafenib—ABCB1—Dexamethasone—asthma	0.000638	0.00273	CbGbCtD
Regorafenib—DDR2—adrenal cortex—asthma	0.000624	0.0191	CbGeAlD
Regorafenib—CYP3A4—Hydrocortisone—asthma	0.000614	0.00263	CbGbCtD
Regorafenib—CYP3A4—Prednisone—asthma	0.000612	0.00262	CbGbCtD
Regorafenib—DDR2—smooth muscle tissue—asthma	0.000599	0.0184	CbGeAlD
Regorafenib—DDR2—cardiovascular system—asthma	0.00057	0.0175	CbGeAlD
Regorafenib—KIT—exocrine gland—asthma	0.000507	0.0155	CbGeAlD
Regorafenib—FLT4—respiratory system—asthma	0.000453	0.0139	CbGeAlD
Regorafenib—DDR2—adrenal gland—asthma	0.000451	0.0138	CbGeAlD
Regorafenib—MAPK11—adrenal gland—asthma	0.000427	0.0131	CbGeAlD
Regorafenib—EPHX2—adrenal cortex—asthma	0.000422	0.0129	CbGeAlD
Regorafenib—DDR2—lung—asthma	0.000395	0.0121	CbGeAlD
Regorafenib—CYP3A4—Dexamethasone—asthma	0.000382	0.00163	CbGbCtD
Regorafenib—FLT4—adrenal cortex—asthma	0.00038	0.0117	CbGeAlD
Regorafenib—FGFR2—respiratory system—asthma	0.00038	0.0117	CbGeAlD
Regorafenib—FLT4—epithelium—asthma	0.000379	0.0116	CbGeAlD
Regorafenib—EPHA2—respiratory system—asthma	0.000374	0.0115	CbGeAlD
Regorafenib—FGFR1—bronchus—asthma	0.000368	0.0113	CbGeAlD
Regorafenib—TEK—respiratory system—asthma	0.000364	0.0112	CbGeAlD
Regorafenib—FLT1—respiratory system—asthma	0.000352	0.0108	CbGeAlD
Regorafenib—RAF1—respiratory system—asthma	0.00035	0.0107	CbGeAlD
Regorafenib—FLT4—cardiovascular system—asthma	0.000347	0.0106	CbGeAlD
Regorafenib—RET—epithelium—asthma	0.000334	0.0103	CbGeAlD
Regorafenib—PDGFRA—respiratory system—asthma	0.00033	0.0101	CbGeAlD
Regorafenib—BRAF—adrenal gland—asthma	0.000319	0.00977	CbGeAlD
Regorafenib—FGFR2—epithelium—asthma	0.000318	0.00974	CbGeAlD
Regorafenib—EPHA2—adrenal cortex—asthma	0.000314	0.00961	CbGeAlD
Regorafenib—EPHA2—epithelium—asthma	0.000312	0.00957	CbGeAlD
Regorafenib—EPHA2—bronchus—asthma	0.000307	0.00943	CbGeAlD
Regorafenib—FGFR2—smooth muscle tissue—asthma	0.000306	0.00939	CbGeAlD
Regorafenib—TEK—adrenal cortex—asthma	0.000306	0.00938	CbGeAlD
Regorafenib—TEK—epithelium—asthma	0.000305	0.00934	CbGeAlD
Regorafenib—EPHX2—adrenal gland—asthma	0.000304	0.00934	CbGeAlD
Regorafenib—TEK—bronchus—asthma	0.0003	0.0092	CbGeAlD
Regorafenib—KDR—respiratory system—asthma	0.000298	0.00913	CbGeAlD
Regorafenib—FLT1—adrenal cortex—asthma	0.000296	0.00907	CbGeAlD
Regorafenib—FLT1—epithelium—asthma	0.000294	0.00903	CbGeAlD
Regorafenib—RAF1—adrenal cortex—asthma	0.000294	0.00902	CbGeAlD
Regorafenib—TEK—smooth muscle tissue—asthma	0.000293	0.009	CbGeAlD
Regorafenib—RAF1—epithelium—asthma	0.000293	0.00898	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—asthma	0.000291	0.00893	CbGeAlD
Regorafenib—FLT1—bronchus—asthma	0.00029	0.00889	CbGeAlD
Regorafenib—RAF1—bronchus—asthma	0.000288	0.00884	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—asthma	0.000286	0.00877	CbGeAlD
Regorafenib—FLT1—smooth muscle tissue—asthma	0.000284	0.0087	CbGeAlD
Regorafenib—RAF1—smooth muscle tissue—asthma	0.000282	0.00865	CbGeAlD
Regorafenib—BRAF—lung—asthma	0.000279	0.00856	CbGeAlD
Regorafenib—TEK—cardiovascular system—asthma	0.000279	0.00856	CbGeAlD
Regorafenib—EPHA2—trachea—asthma	0.000276	0.00847	CbGeAlD
Regorafenib—FLT4—adrenal gland—asthma	0.000275	0.00842	CbGeAlD
Regorafenib—FGFR1—adrenal gland—asthma	0.000271	0.00831	CbGeAlD
Regorafenib—FLT1—cardiovascular system—asthma	0.00027	0.00828	CbGeAlD
Regorafenib—RAF1—cardiovascular system—asthma	0.000268	0.00823	CbGeAlD
Regorafenib—EPHX2—lung—asthma	0.000267	0.00818	CbGeAlD
Regorafenib—PDGFRA—smooth muscle tissue—asthma	0.000266	0.00815	CbGeAlD
Regorafenib—KIT—respiratory system—asthma	0.000264	0.00809	CbGeAlD
Regorafenib—FLT1—trachea—asthma	0.00026	0.00799	CbGeAlD
Regorafenib—RAF1—trachea—asthma	0.000259	0.00794	CbGeAlD
Regorafenib—PDGFRB—respiratory system—asthma	0.000258	0.00791	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—asthma	0.000253	0.00776	CbGeAlD
Regorafenib—KDR—adrenal cortex—asthma	0.00025	0.00767	CbGeAlD
Regorafenib—KDR—epithelium—asthma	0.000249	0.00763	CbGeAlD
Regorafenib—KDR—bronchus—asthma	0.000245	0.00752	CbGeAlD
Regorafenib—PDGFRA—trachea—asthma	0.000244	0.00748	CbGeAlD
Regorafenib—RET—adrenal gland—asthma	0.000242	0.00743	CbGeAlD
Regorafenib—FLT4—lung—asthma	0.000241	0.00738	CbGeAlD
Regorafenib—KDR—smooth muscle tissue—asthma	0.00024	0.00736	CbGeAlD
Regorafenib—FGFR1—lung—asthma	0.000237	0.00728	CbGeAlD
Regorafenib—FGFR2—adrenal gland—asthma	0.00023	0.00706	CbGeAlD
Regorafenib—ABL1—respiratory system—asthma	0.00023	0.00705	CbGeAlD
Regorafenib—KDR—cardiovascular system—asthma	0.000228	0.007	CbGeAlD
Regorafenib—EPHA2—adrenal gland—asthma	0.000226	0.00694	CbGeAlD
Regorafenib—TEK—adrenal gland—asthma	0.000221	0.00677	CbGeAlD
Regorafenib—KIT—epithelium—asthma	0.000221	0.00676	CbGeAlD
Regorafenib—KDR—trachea—asthma	0.00022	0.00675	CbGeAlD
Regorafenib—KIT—bronchus—asthma	0.000217	0.00666	CbGeAlD
Regorafenib—PDGFRB—adrenal cortex—asthma	0.000216	0.00664	CbGeAlD
Regorafenib—PDGFRB—epithelium—asthma	0.000215	0.00661	CbGeAlD
Regorafenib—FLT1—adrenal gland—asthma	0.000213	0.00655	CbGeAlD
Regorafenib—KIT—smooth muscle tissue—asthma	0.000213	0.00652	CbGeAlD
Regorafenib—RAF1—adrenal gland—asthma	0.000212	0.00651	CbGeAlD
Regorafenib—PDGFRB—bronchus—asthma	0.000212	0.00651	CbGeAlD
Regorafenib—PDGFRB—smooth muscle tissue—asthma	0.000208	0.00637	CbGeAlD
Regorafenib—KIT—cardiovascular system—asthma	0.000202	0.0062	CbGeAlD
Regorafenib—FGFR2—lung—asthma	0.000202	0.00619	CbGeAlD
Regorafenib—PDGFRA—adrenal gland—asthma	0.0002	0.00613	CbGeAlD
Regorafenib—EPHA2—lung—asthma	0.000198	0.00608	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—asthma	0.000197	0.00606	CbGeAlD
Regorafenib—KIT—trachea—asthma	0.000195	0.00598	CbGeAlD
Regorafenib—TEK—lung—asthma	0.000194	0.00593	CbGeAlD
Regorafenib—ABL1—adrenal cortex—asthma	0.000193	0.00591	CbGeAlD
Regorafenib—PDGFRB—trachea—asthma	0.000191	0.00584	CbGeAlD
Regorafenib—ABL1—bronchus—asthma	0.000189	0.0058	CbGeAlD
Regorafenib—FLT1—lung—asthma	0.000187	0.00574	CbGeAlD
Regorafenib—RAF1—lung—asthma	0.000186	0.0057	CbGeAlD
Regorafenib—ABL1—smooth muscle tissue—asthma	0.000185	0.00567	CbGeAlD
Regorafenib—KDR—adrenal gland—asthma	0.00018	0.00553	CbGeAlD
Regorafenib—ABL1—cardiovascular system—asthma	0.000176	0.0054	CbGeAlD
Regorafenib—PDGFRA—lung—asthma	0.000175	0.00538	CbGeAlD
Regorafenib—ABL1—trachea—asthma	0.00017	0.00521	CbGeAlD
Regorafenib—KIT—adrenal gland—asthma	0.00016	0.0049	CbGeAlD
Regorafenib—KDR—lung—asthma	0.000158	0.00485	CbGeAlD
Regorafenib—PDGFRB—adrenal gland—asthma	0.000156	0.00479	CbGeAlD
Regorafenib—KIT—lung—asthma	0.00014	0.0043	CbGeAlD
Regorafenib—ABL1—adrenal gland—asthma	0.000139	0.00427	CbGeAlD
Regorafenib—PDGFRB—lung—asthma	0.000137	0.0042	CbGeAlD
Regorafenib—CYP2B6—respiratory system—asthma	0.000134	0.0041	CbGeAlD
Regorafenib—ABL1—lung—asthma	0.000122	0.00374	CbGeAlD
Regorafenib—ABCG2—adrenal cortex—asthma	0.000122	0.00373	CbGeAlD
Regorafenib—CYP2B6—adrenal cortex—asthma	0.000112	0.00344	CbGeAlD
Regorafenib—CYP2B6—bronchus—asthma	0.00011	0.00337	CbGeAlD
Regorafenib—CYP2B6—cardiovascular system—asthma	0.000102	0.00314	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—asthma	0.000101	0.00311	CbGeAlD
Regorafenib—ABCG2—adrenal gland—asthma	8.78e-05	0.00269	CbGeAlD
Regorafenib—CYP2B6—adrenal gland—asthma	8.1e-05	0.00248	CbGeAlD
Regorafenib—ABCG2—lung—asthma	7.69e-05	0.00236	CbGeAlD
Regorafenib—ABCB1—respiratory system—asthma	7.15e-05	0.00219	CbGeAlD
Regorafenib—CYP2B6—lung—asthma	7.1e-05	0.00218	CbGeAlD
Regorafenib—ABCB1—adrenal cortex—asthma	6e-05	0.00184	CbGeAlD
Regorafenib—ABCB1—epithelium—asthma	5.97e-05	0.00183	CbGeAlD
Regorafenib—ABCB1—cardiovascular system—asthma	5.47e-05	0.00168	CbGeAlD
Regorafenib—ABCB1—trachea—asthma	5.28e-05	0.00162	CbGeAlD
Regorafenib—Hypokalaemia—Dexamethasone—asthma	4.36e-05	0.000743	CcSEcCtD
Regorafenib—Hypokalaemia—Betamethasone—asthma	4.36e-05	0.000743	CcSEcCtD
Regorafenib—Vomiting—Aminophylline—asthma	4.35e-05	0.000742	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisolone—asthma	4.34e-05	0.000739	CcSEcCtD
Regorafenib—ABCB1—adrenal gland—asthma	4.33e-05	0.00133	CbGeAlD
Regorafenib—Infestation NOS—Hydrocortisone—asthma	4.32e-05	0.000737	CcSEcCtD
Regorafenib—Infestation—Hydrocortisone—asthma	4.32e-05	0.000737	CcSEcCtD
Regorafenib—Rash—Aminophylline—asthma	4.32e-05	0.000736	CcSEcCtD
Regorafenib—Dermatitis—Aminophylline—asthma	4.31e-05	0.000735	CcSEcCtD
Regorafenib—Asthenia—Flunisolide—asthma	4.29e-05	0.000732	CcSEcCtD
Regorafenib—Nausea—Fluticasone Propionate—asthma	4.29e-05	0.000732	CcSEcCtD
Regorafenib—Headache—Aminophylline—asthma	4.29e-05	0.000731	CcSEcCtD
Regorafenib—Nausea—Salmeterol—asthma	4.28e-05	0.00073	CcSEcCtD
Regorafenib—Decreased appetite—Salbutamol—asthma	4.28e-05	0.000729	CcSEcCtD
Regorafenib—Gastrointestinal pain—Formoterol—asthma	4.26e-05	0.000726	CcSEcCtD
Regorafenib—Gastrointestinal pain—Arformoterol—asthma	4.26e-05	0.000726	CcSEcCtD
Regorafenib—Acute coronary syndrome—Hydrocortisone—asthma	4.26e-05	0.000726	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Salbutamol—asthma	4.25e-05	0.000724	CcSEcCtD
Regorafenib—Fatigue—Salbutamol—asthma	4.24e-05	0.000723	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrocortisone—asthma	4.24e-05	0.000722	CcSEcCtD
Regorafenib—Pain—Salbutamol—asthma	4.21e-05	0.000717	CcSEcCtD
Regorafenib—Gastrointestinal pain—Montelukast—asthma	4.17e-05	0.000712	CcSEcCtD
Regorafenib—Decreased appetite—Budesonide—asthma	4.14e-05	0.000706	CcSEcCtD
Regorafenib—Body temperature increased—Formoterol—asthma	4.12e-05	0.000702	CcSEcCtD
Regorafenib—Abdominal pain—Arformoterol—asthma	4.12e-05	0.000702	CcSEcCtD
Regorafenib—Body temperature increased—Arformoterol—asthma	4.12e-05	0.000702	CcSEcCtD
Regorafenib—Abdominal pain—Formoterol—asthma	4.12e-05	0.000702	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Budesonide—asthma	4.11e-05	0.000701	CcSEcCtD
Regorafenib—Vomiting—Loratadine—asthma	4.11e-05	0.000701	CcSEcCtD
Regorafenib—Fatigue—Budesonide—asthma	4.11e-05	0.000701	CcSEcCtD
Regorafenib—Vomiting—Tiotropium—asthma	4.11e-05	0.0007	CcSEcCtD
Regorafenib—Diarrhoea—Flunisolide—asthma	4.09e-05	0.000698	CcSEcCtD
Regorafenib—Rash—Loratadine—asthma	4.08e-05	0.000695	CcSEcCtD
Regorafenib—Pain—Budesonide—asthma	4.08e-05	0.000695	CcSEcCtD
Regorafenib—Dermatitis—Loratadine—asthma	4.07e-05	0.000695	CcSEcCtD
Regorafenib—Rash—Tiotropium—asthma	4.07e-05	0.000694	CcSEcCtD
Regorafenib—Dermatitis—Tiotropium—asthma	4.07e-05	0.000693	CcSEcCtD
Regorafenib—Nausea—Aminophylline—asthma	4.07e-05	0.000693	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—asthma	4.06e-05	0.000692	CcSEcCtD
Regorafenib—Infestation—Methylprednisolone—asthma	4.06e-05	0.000692	CcSEcCtD
Regorafenib—Headache—Loratadine—asthma	4.05e-05	0.000691	CcSEcCtD
Regorafenib—Headache—Tiotropium—asthma	4.05e-05	0.00069	CcSEcCtD
Regorafenib—Abdominal pain—Montelukast—asthma	4.03e-05	0.000688	CcSEcCtD
Regorafenib—Body temperature increased—Montelukast—asthma	4.03e-05	0.000688	CcSEcCtD
Regorafenib—Gastrointestinal pain—Salbutamol—asthma	4.02e-05	0.000686	CcSEcCtD
Regorafenib—Acute coronary syndrome—Triamcinolone—asthma	4.01e-05	0.000684	CcSEcCtD
Regorafenib—Acute coronary syndrome—Methylprednisolone—asthma	4e-05	0.000682	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—asthma	3.99e-05	0.000681	CcSEcCtD
Regorafenib—Myocardial infarction—Triamcinolone—asthma	3.99e-05	0.00068	CcSEcCtD
Regorafenib—Asthenia—Mometasone—asthma	3.98e-05	0.000679	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—asthma	3.98e-05	0.000678	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—asthma	3.97e-05	0.000677	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—asthma	3.9e-05	0.000665	CcSEcCtD
Regorafenib—Gastrointestinal pain—Budesonide—asthma	3.9e-05	0.000664	CcSEcCtD
Regorafenib—Abdominal pain—Salbutamol—asthma	3.89e-05	0.000663	CcSEcCtD
Regorafenib—Body temperature increased—Salbutamol—asthma	3.89e-05	0.000663	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—asthma	3.88e-05	0.000661	CcSEcCtD
Regorafenib—Nausea—Loratadine—asthma	3.84e-05	0.000655	CcSEcCtD
Regorafenib—Nausea—Tiotropium—asthma	3.84e-05	0.000654	CcSEcCtD
Regorafenib—Dry skin—Prednisone—asthma	3.82e-05	0.000652	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—asthma	3.81e-05	0.00065	CcSEcCtD
Regorafenib—Vomiting—Flunisolide—asthma	3.81e-05	0.000649	CcSEcCtD
Regorafenib—Diarrhoea—Mometasone—asthma	3.8e-05	0.000648	CcSEcCtD
Regorafenib—Hypokalaemia—Prednisone—asthma	3.8e-05	0.000647	CcSEcCtD
Regorafenib—ABCB1—lung—asthma	3.79e-05	0.00116	CbGeAlD
Regorafenib—Rash—Flunisolide—asthma	3.77e-05	0.000643	CcSEcCtD
Regorafenib—Dermatitis—Flunisolide—asthma	3.77e-05	0.000643	CcSEcCtD
Regorafenib—Abdominal pain—Budesonide—asthma	3.77e-05	0.000642	CcSEcCtD
Regorafenib—Body temperature increased—Budesonide—asthma	3.77e-05	0.000642	CcSEcCtD
Regorafenib—Headache—Flunisolide—asthma	3.75e-05	0.000639	CcSEcCtD
Regorafenib—Weight decreased—Betamethasone—asthma	3.75e-05	0.000639	CcSEcCtD
Regorafenib—Weight decreased—Dexamethasone—asthma	3.75e-05	0.000639	CcSEcCtD
Regorafenib—Asthenia—Arformoterol—asthma	3.74e-05	0.000637	CcSEcCtD
Regorafenib—Asthenia—Formoterol—asthma	3.74e-05	0.000637	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Prednisone—asthma	3.68e-05	0.000627	CcSEcCtD
Regorafenib—Haemoglobin—Triamcinolone—asthma	3.67e-05	0.000626	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—asthma	3.66e-05	0.000625	CcSEcCtD
Regorafenib—Asthenia—Montelukast—asthma	3.66e-05	0.000624	CcSEcCtD
Regorafenib—Haemorrhage—Triamcinolone—asthma	3.65e-05	0.000623	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—asthma	3.64e-05	0.000621	CcSEcCtD
Regorafenib—Acute coronary syndrome—Betamethasone—asthma	3.64e-05	0.00062	CcSEcCtD
Regorafenib—Acute coronary syndrome—Dexamethasone—asthma	3.64e-05	0.00062	CcSEcCtD
Regorafenib—Myocardial infarction—Betamethasone—asthma	3.62e-05	0.000617	CcSEcCtD
Regorafenib—Myocardial infarction—Dexamethasone—asthma	3.62e-05	0.000617	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—asthma	3.58e-05	0.000611	CcSEcCtD
Regorafenib—Diarrhoea—Formoterol—asthma	3.57e-05	0.000608	CcSEcCtD
Regorafenib—Diarrhoea—Arformoterol—asthma	3.57e-05	0.000608	CcSEcCtD
Regorafenib—Nausea—Flunisolide—asthma	3.55e-05	0.000606	CcSEcCtD
Regorafenib—Asthenia—Salbutamol—asthma	3.53e-05	0.000602	CcSEcCtD
Regorafenib—Vomiting—Mometasone—asthma	3.53e-05	0.000602	CcSEcCtD
Regorafenib—Rash—Mometasone—asthma	3.5e-05	0.000597	CcSEcCtD
Regorafenib—Dermatitis—Mometasone—asthma	3.5e-05	0.000596	CcSEcCtD
Regorafenib—Diarrhoea—Montelukast—asthma	3.49e-05	0.000595	CcSEcCtD
Regorafenib—Headache—Mometasone—asthma	3.48e-05	0.000593	CcSEcCtD
Regorafenib—Asthenia—Budesonide—asthma	3.42e-05	0.000583	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—asthma	3.38e-05	0.000577	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—asthma	3.38e-05	0.000576	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—asthma	3.37e-05	0.000575	CcSEcCtD
Regorafenib—Diarrhoea—Salbutamol—asthma	3.37e-05	0.000574	CcSEcCtD
Regorafenib—Haemoglobin—Dexamethasone—asthma	3.33e-05	0.000568	CcSEcCtD
Regorafenib—Haemoglobin—Betamethasone—asthma	3.33e-05	0.000568	CcSEcCtD
Regorafenib—Haemorrhage—Betamethasone—asthma	3.31e-05	0.000565	CcSEcCtD
Regorafenib—Haemorrhage—Dexamethasone—asthma	3.31e-05	0.000565	CcSEcCtD
Regorafenib—Vomiting—Arformoterol—asthma	3.31e-05	0.000565	CcSEcCtD
Regorafenib—Vomiting—Formoterol—asthma	3.31e-05	0.000565	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—asthma	3.31e-05	0.000564	CcSEcCtD
Regorafenib—Nausea—Mometasone—asthma	3.3e-05	0.000562	CcSEcCtD
Regorafenib—Rash—Formoterol—asthma	3.29e-05	0.00056	CcSEcCtD
Regorafenib—Rash—Arformoterol—asthma	3.29e-05	0.00056	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—asthma	3.28e-05	0.00056	CcSEcCtD
Regorafenib—Dermatitis—Formoterol—asthma	3.28e-05	0.00056	CcSEcCtD
Regorafenib—Dermatitis—Arformoterol—asthma	3.28e-05	0.00056	CcSEcCtD
Regorafenib—Headache—Formoterol—asthma	3.26e-05	0.000557	CcSEcCtD
Regorafenib—Headache—Arformoterol—asthma	3.26e-05	0.000557	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—asthma	3.26e-05	0.000556	CcSEcCtD
Regorafenib—Diarrhoea—Budesonide—asthma	3.26e-05	0.000556	CcSEcCtD
Regorafenib—Vomiting—Montelukast—asthma	3.25e-05	0.000553	CcSEcCtD
Regorafenib—Rash—Montelukast—asthma	3.22e-05	0.000549	CcSEcCtD
Regorafenib—Dermatitis—Montelukast—asthma	3.22e-05	0.000548	CcSEcCtD
Regorafenib—Headache—Montelukast—asthma	3.2e-05	0.000545	CcSEcCtD
Regorafenib—Malnutrition—Methylprednisolone—asthma	3.17e-05	0.000541	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—asthma	3.17e-05	0.00054	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—asthma	3.15e-05	0.000537	CcSEcCtD
Regorafenib—Vomiting—Salbutamol—asthma	3.13e-05	0.000533	CcSEcCtD
Regorafenib—Rash—Salbutamol—asthma	3.1e-05	0.000529	CcSEcCtD
Regorafenib—Dermatitis—Salbutamol—asthma	3.1e-05	0.000528	CcSEcCtD
Regorafenib—Nausea—Arformoterol—asthma	3.1e-05	0.000528	CcSEcCtD
Regorafenib—Nausea—Formoterol—asthma	3.1e-05	0.000528	CcSEcCtD
Regorafenib—Headache—Salbutamol—asthma	3.08e-05	0.000525	CcSEcCtD
Regorafenib—Nausea—Montelukast—asthma	3.03e-05	0.000517	CcSEcCtD
Regorafenib—Vomiting—Budesonide—asthma	3.03e-05	0.000517	CcSEcCtD
Regorafenib—Angiopathy—Betamethasone—asthma	3.01e-05	0.000513	CcSEcCtD
Regorafenib—Angiopathy—Dexamethasone—asthma	3.01e-05	0.000513	CcSEcCtD
Regorafenib—Rash—Budesonide—asthma	3.01e-05	0.000512	CcSEcCtD
Regorafenib—Dermatitis—Budesonide—asthma	3e-05	0.000512	CcSEcCtD
Regorafenib—Headache—Budesonide—asthma	2.99e-05	0.000509	CcSEcCtD
Regorafenib—Hypertension—Prednisolone—asthma	2.99e-05	0.000509	CcSEcCtD
Regorafenib—Alopecia—Betamethasone—asthma	2.93e-05	0.000499	CcSEcCtD
Regorafenib—Alopecia—Dexamethasone—asthma	2.93e-05	0.000499	CcSEcCtD
Regorafenib—Nausea—Salbutamol—asthma	2.92e-05	0.000498	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—asthma	2.92e-05	0.000497	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—asthma	2.9e-05	0.000495	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—asthma	2.89e-05	0.000492	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.86e-05	0.000487	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—asthma	2.84e-05	0.000484	CcSEcCtD
Regorafenib—Nausea—Budesonide—asthma	2.83e-05	0.000483	CcSEcCtD
Regorafenib—Hypertension—Triamcinolone—asthma	2.75e-05	0.000468	CcSEcCtD
Regorafenib—Hypertension—Methylprednisolone—asthma	2.74e-05	0.000467	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—asthma	2.74e-05	0.000467	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—asthma	2.7e-05	0.000461	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.68e-05	0.000457	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—asthma	2.68e-05	0.000456	CcSEcCtD
Regorafenib—Dry mouth—Triamcinolone—asthma	2.65e-05	0.000451	CcSEcCtD
Regorafenib—Angiopathy—Prednisone—asthma	2.62e-05	0.000446	CcSEcCtD
Regorafenib—Infection—Triamcinolone—asthma	2.58e-05	0.00044	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—asthma	2.57e-05	0.000439	CcSEcCtD
Regorafenib—Alopecia—Prednisone—asthma	2.55e-05	0.000435	CcSEcCtD
Regorafenib—Nervous system disorder—Methylprednisolone—asthma	2.54e-05	0.000433	CcSEcCtD
Regorafenib—Skin disorder—Methylprednisolone—asthma	2.52e-05	0.000429	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—asthma	2.51e-05	0.000428	CcSEcCtD
Regorafenib—Hypertension—Betamethasone—asthma	2.49e-05	0.000425	CcSEcCtD
Regorafenib—Hypertension—Dexamethasone—asthma	2.49e-05	0.000425	CcSEcCtD
Regorafenib—Pain—Prednisolone—asthma	2.41e-05	0.000411	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—asthma	2.4e-05	0.000408	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—asthma	2.38e-05	0.000406	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—asthma	2.38e-05	0.000405	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—asthma	2.36e-05	0.000402	CcSEcCtD
Regorafenib—Infection—Dexamethasone—asthma	2.34e-05	0.000399	CcSEcCtD
Regorafenib—Infection—Betamethasone—asthma	2.34e-05	0.000399	CcSEcCtD
Regorafenib—Anaemia—Prednisone—asthma	2.32e-05	0.000396	CcSEcCtD
Regorafenib—Nervous system disorder—Dexamethasone—asthma	2.31e-05	0.000394	CcSEcCtD
Regorafenib—Nervous system disorder—Betamethasone—asthma	2.31e-05	0.000394	CcSEcCtD
Regorafenib—Thrombocytopenia—Dexamethasone—asthma	2.31e-05	0.000393	CcSEcCtD
Regorafenib—Thrombocytopenia—Betamethasone—asthma	2.31e-05	0.000393	CcSEcCtD
Regorafenib—Gastrointestinal pain—Hydrocortisone—asthma	2.25e-05	0.000384	CcSEcCtD
Regorafenib—Fatigue—Triamcinolone—asthma	2.24e-05	0.000381	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—asthma	2.23e-05	0.000381	CcSEcCtD
Regorafenib—Pain—Triamcinolone—asthma	2.22e-05	0.000378	CcSEcCtD
Regorafenib—Abdominal pain—Hydrocortisone—asthma	2.18e-05	0.000371	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—asthma	2.18e-05	0.000371	CcSEcCtD
Regorafenib—Hypertension—Prednisone—asthma	2.17e-05	0.00037	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.12e-05	0.000362	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—asthma	2.12e-05	0.000361	CcSEcCtD
Regorafenib—Body temperature increased—Triamcinolone—asthma	2.05e-05	0.00035	CcSEcCtD
Regorafenib—Abdominal pain—Methylprednisolone—asthma	2.05e-05	0.000349	CcSEcCtD
Regorafenib—Decreased appetite—Betamethasone—asthma	2.05e-05	0.000349	CcSEcCtD
Regorafenib—Decreased appetite—Dexamethasone—asthma	2.05e-05	0.000349	CcSEcCtD
Regorafenib—Infection—Prednisone—asthma	2.04e-05	0.000347	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Betamethasone—asthma	2.03e-05	0.000347	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Dexamethasone—asthma	2.03e-05	0.000347	CcSEcCtD
Regorafenib—Fatigue—Betamethasone—asthma	2.03e-05	0.000346	CcSEcCtD
Regorafenib—Fatigue—Dexamethasone—asthma	2.03e-05	0.000346	CcSEcCtD
Regorafenib—Pain—Dexamethasone—asthma	2.01e-05	0.000343	CcSEcCtD
Regorafenib—Pain—Betamethasone—asthma	2.01e-05	0.000343	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—asthma	2.01e-05	0.000343	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—asthma	1.99e-05	0.00034	CcSEcCtD
Regorafenib—Asthenia—Hydrocortisone—asthma	1.98e-05	0.000337	CcSEcCtD
Regorafenib—Gastrointestinal pain—Betamethasone—asthma	1.93e-05	0.000328	CcSEcCtD
Regorafenib—Gastrointestinal pain—Dexamethasone—asthma	1.93e-05	0.000328	CcSEcCtD
Regorafenib—Diarrhoea—Hydrocortisone—asthma	1.89e-05	0.000321	CcSEcCtD
Regorafenib—Asthenia—Triamcinolone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Body temperature increased—Dexamethasone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Abdominal pain—Betamethasone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Abdominal pain—Dexamethasone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Body temperature increased—Betamethasone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Asthenia—Methylprednisolone—asthma	1.86e-05	0.000317	CcSEcCtD
Regorafenib—Decreased appetite—Prednisone—asthma	1.78e-05	0.000304	CcSEcCtD
Regorafenib—Rash—Prednisolone—asthma	1.78e-05	0.000303	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—asthma	1.78e-05	0.000303	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—asthma	1.77e-05	0.000302	CcSEcCtD
Regorafenib—Fatigue—Prednisone—asthma	1.77e-05	0.000301	CcSEcCtD
Regorafenib—Headache—Prednisolone—asthma	1.77e-05	0.000301	CcSEcCtD
Regorafenib—Vomiting—Hydrocortisone—asthma	1.75e-05	0.000299	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—asthma	1.74e-05	0.000296	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—asthma	1.74e-05	0.000296	CcSEcCtD
Regorafenib—Headache—Hydrocortisone—asthma	1.73e-05	0.000294	CcSEcCtD
Regorafenib—Asthenia—Dexamethasone—asthma	1.69e-05	0.000288	CcSEcCtD
Regorafenib—Asthenia—Betamethasone—asthma	1.69e-05	0.000288	CcSEcCtD
Regorafenib—Gastrointestinal pain—Prednisone—asthma	1.68e-05	0.000286	CcSEcCtD
Regorafenib—Nausea—Prednisolone—asthma	1.68e-05	0.000286	CcSEcCtD
Regorafenib—Vomiting—Triamcinolone—asthma	1.65e-05	0.000281	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—asthma	1.65e-05	0.000281	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—asthma	1.64e-05	0.000279	CcSEcCtD
Regorafenib—Rash—Triamcinolone—asthma	1.64e-05	0.000279	CcSEcCtD
Regorafenib—Dermatitis—Triamcinolone—asthma	1.63e-05	0.000279	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—asthma	1.63e-05	0.000278	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—asthma	1.63e-05	0.000278	CcSEcCtD
Regorafenib—Headache—Triamcinolone—asthma	1.63e-05	0.000277	CcSEcCtD
Regorafenib—Headache—Methylprednisolone—asthma	1.62e-05	0.000277	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—asthma	1.62e-05	0.000276	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—asthma	1.62e-05	0.000276	CcSEcCtD
Regorafenib—Diarrhoea—Betamethasone—asthma	1.61e-05	0.000275	CcSEcCtD
Regorafenib—Diarrhoea—Dexamethasone—asthma	1.61e-05	0.000275	CcSEcCtD
Regorafenib—Nausea—Triamcinolone—asthma	1.54e-05	0.000263	CcSEcCtD
Regorafenib—Nausea—Methylprednisolone—asthma	1.54e-05	0.000262	CcSEcCtD
Regorafenib—Vomiting—Dexamethasone—asthma	1.5e-05	0.000255	CcSEcCtD
Regorafenib—Vomiting—Betamethasone—asthma	1.5e-05	0.000255	CcSEcCtD
Regorafenib—Rash—Betamethasone—asthma	1.48e-05	0.000253	CcSEcCtD
Regorafenib—Rash—Dexamethasone—asthma	1.48e-05	0.000253	CcSEcCtD
Regorafenib—Dermatitis—Betamethasone—asthma	1.48e-05	0.000253	CcSEcCtD
Regorafenib—Dermatitis—Dexamethasone—asthma	1.48e-05	0.000253	CcSEcCtD
Regorafenib—Headache—Dexamethasone—asthma	1.48e-05	0.000251	CcSEcCtD
Regorafenib—Headache—Betamethasone—asthma	1.48e-05	0.000251	CcSEcCtD
Regorafenib—Asthenia—Prednisone—asthma	1.47e-05	0.000251	CcSEcCtD
Regorafenib—Diarrhoea—Prednisone—asthma	1.4e-05	0.000239	CcSEcCtD
Regorafenib—Nausea—Betamethasone—asthma	1.4e-05	0.000238	CcSEcCtD
Regorafenib—Nausea—Dexamethasone—asthma	1.4e-05	0.000238	CcSEcCtD
Regorafenib—Vomiting—Prednisone—asthma	1.3e-05	0.000222	CcSEcCtD
Regorafenib—Rash—Prednisone—asthma	1.29e-05	0.00022	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—asthma	1.29e-05	0.00022	CcSEcCtD
Regorafenib—Headache—Prednisone—asthma	1.28e-05	0.000219	CcSEcCtD
Regorafenib—Nausea—Prednisone—asthma	1.22e-05	0.000208	CcSEcCtD
Regorafenib—RAF1—Disease—PTGS2—asthma	1.01e-06	1.68e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SERPINE1—asthma	1.01e-06	1.67e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CXCL8—asthma	1e-06	1.66e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—VEGFA—asthma	9.99e-07	1.66e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—asthma	9.94e-07	1.65e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ALB—asthma	9.93e-07	1.65e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ALB—asthma	9.93e-07	1.65e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CXCL8—asthma	9.91e-07	1.64e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—STAT3—asthma	9.9e-07	1.64e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTEN—asthma	9.87e-07	1.64e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—STAT3—asthma	9.83e-07	1.63e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—asthma	9.82e-07	1.63e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—STAT3—asthma	9.8e-07	1.63e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—TGFB1—asthma	9.77e-07	1.62e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—RHOA—asthma	9.75e-07	1.62e-05	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	9.73e-07	1.61e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FN1—asthma	9.73e-07	1.61e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—asthma	9.73e-07	1.61e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—RHOA—asthma	9.72e-07	1.61e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6R—asthma	9.7e-07	1.61e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—EGFR—asthma	9.67e-07	1.61e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—EGFR—asthma	9.65e-07	1.6e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NOS3—asthma	9.65e-07	1.6e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NOS3—asthma	9.62e-07	1.6e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—TGFB1—asthma	9.6e-07	1.59e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—GSTM1—asthma	9.58e-07	1.59e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PLA2G4A—asthma	9.58e-07	1.59e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—EGFR—asthma	9.58e-07	1.59e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—STAT3—asthma	9.56e-07	1.59e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—asthma	9.56e-07	1.59e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	9.56e-07	1.59e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PTEN—asthma	9.53e-07	1.58e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—NOS3—asthma	9.5e-07	1.58e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—NOS3—asthma	9.5e-07	1.58e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—asthma	9.47e-07	1.57e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NQO1—asthma	9.45e-07	1.57e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—VEGFA—asthma	9.44e-07	1.57e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—EGFR—asthma	9.41e-07	1.56e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—STAT3—asthma	9.35e-07	1.55e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—STAT3—asthma	9.32e-07	1.55e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ADCY2—asthma	9.25e-07	1.54e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALOX5AP—asthma	9.24e-07	1.53e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALOX15—asthma	9.24e-07	1.53e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—asthma	9.24e-07	1.53e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NQO1—asthma	9.22e-07	1.53e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CXCL8—asthma	9.18e-07	1.52e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—TGFB1—asthma	9.17e-07	1.52e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	9.17e-07	1.52e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—TGFB1—asthma	9.11e-07	1.51e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—TGFB1—asthma	9.09e-07	1.51e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SERPINE1—asthma	9.08e-07	1.51e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—asthma	9.04e-07	1.5e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ADCY2—asthma	9.03e-07	1.5e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CXCL8—asthma	9.02e-07	1.5e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—EGFR—asthma	8.99e-07	1.49e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PTEN—asthma	8.99e-07	1.49e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—asthma	8.96e-07	1.49e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	8.96e-07	1.49e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—EGFR—asthma	8.93e-07	1.48e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—EGFR—asthma	8.91e-07	1.48e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PTEN—asthma	8.91e-07	1.48e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—asthma	8.86e-07	1.47e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—STAT3—asthma	8.83e-07	1.47e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GSTP1—asthma	8.83e-07	1.47e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPP2CA—asthma	8.83e-07	1.47e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CHAT—asthma	8.82e-07	1.46e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTEN—asthma	8.8e-07	1.46e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—asthma	8.77e-07	1.46e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—RHOA—asthma	8.76e-07	1.45e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—HMOX1—asthma	8.71e-07	1.45e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—EGFR—asthma	8.69e-07	1.44e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ITPR1—asthma	8.69e-07	1.44e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—asthma	8.69e-07	1.44e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—asthma	8.69e-07	1.44e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—asthma	8.69e-07	1.44e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—TGFB1—asthma	8.67e-07	1.44e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NOS3—asthma	8.67e-07	1.44e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—asthma	8.67e-07	1.44e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6R—asthma	8.64e-07	1.43e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—asthma	8.62e-07	1.43e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NQO1—asthma	8.62e-07	1.43e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CAT—asthma	8.59e-07	1.43e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CXCL8—asthma	8.56e-07	1.42e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CXCL8—asthma	8.53e-07	1.42e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—STAT3—asthma	8.52e-07	1.42e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—EGFR—asthma	8.5e-07	1.41e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—EGFR—asthma	8.48e-07	1.41e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—EGFR—asthma	8.47e-07	1.41e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ADCY2—asthma	8.43e-07	1.4e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—ALB—asthma	8.43e-07	1.4e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.36e-07	1.39e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—asthma	8.3e-07	1.38e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PTEN—asthma	8.26e-07	1.37e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—TGFB1—asthma	8.19e-07	1.36e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—asthma	8.18e-07	1.36e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—asthma	8.16e-07	1.35e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—asthma	8.16e-07	1.35e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—VEGFA—asthma	8.12e-07	1.35e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PLA2G4A—asthma	8.11e-07	1.35e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GSTM1—asthma	8.11e-07	1.35e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PTEN—asthma	8.11e-07	1.35e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SERPINE1—asthma	8.09e-07	1.34e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—NOS3—asthma	8.06e-07	1.34e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—VEGFA—asthma	8.05e-07	1.34e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—STAT3—asthma	8.04e-07	1.34e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—EGFR—asthma	8.03e-07	1.33e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	8e-07	1.33e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—asthma	7.98e-07	1.32e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—STAT3—asthma	7.97e-07	1.32e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—asthma	7.95e-07	1.32e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTP1—asthma	7.88e-07	1.31e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—STAT3—asthma	7.87e-07	1.31e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALOX5—asthma	7.86e-07	1.31e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—asthma	7.83e-07	1.3e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—RHOA—asthma	7.81e-07	1.3e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HMOX1—asthma	7.77e-07	1.29e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ITPR1—asthma	7.76e-07	1.29e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—EGFR—asthma	7.75e-07	1.29e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—asthma	7.74e-07	1.29e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—asthma	7.73e-07	1.28e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—asthma	7.72e-07	1.28e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PTEN—asthma	7.69e-07	1.28e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTP1—asthma	7.69e-07	1.28e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—asthma	7.69e-07	1.28e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PTEN—asthma	7.67e-07	1.27e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—asthma	7.67e-07	1.27e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HMOX1—asthma	7.59e-07	1.26e-05	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTEN—asthma	7.58e-07	1.26e-05	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTEN—asthma	7.58e-07	1.26e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ITPR1—asthma	7.57e-07	1.26e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CARM1—asthma	7.5e-07	1.24e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—asthma	7.49e-07	1.24e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPP2CA—asthma	7.47e-07	1.24e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VEGFA—asthma	7.46e-07	1.24e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—asthma	7.45e-07	1.24e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—asthma	7.43e-07	1.23e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—asthma	7.42e-07	1.23e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DCN—asthma	7.39e-07	1.23e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—asthma	7.38e-07	1.23e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—STAT3—asthma	7.38e-07	1.23e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—asthma	7.37e-07	1.22e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—asthma	7.36e-07	1.22e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—asthma	7.35e-07	1.22e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VEGFA—asthma	7.32e-07	1.22e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—EGFR—asthma	7.31e-07	1.21e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—asthma	7.3e-07	1.21e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	7.29e-07	1.21e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—STAT3—asthma	7.25e-07	1.2e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PLA2G4A—asthma	7.24e-07	1.2e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTM1—asthma	7.24e-07	1.2e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—EGFR—asthma	7.24e-07	1.2e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—asthma	7.23e-07	1.2e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALDH2—asthma	7.19e-07	1.19e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTP1—asthma	7.19e-07	1.19e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—EGFR—asthma	7.15e-07	1.19e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HMOX1—asthma	7.09e-07	1.18e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ITPR1—asthma	7.07e-07	1.17e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PLA2G4A—asthma	7.07e-07	1.17e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTM1—asthma	7.07e-07	1.17e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—asthma	6.99e-07	1.16e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—asthma	6.95e-07	1.15e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VEGFA—asthma	6.95e-07	1.15e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VEGFA—asthma	6.93e-07	1.15e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PTEN—asthma	6.91e-07	1.15e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—asthma	6.91e-07	1.15e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—STAT3—asthma	6.88e-07	1.14e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—asthma	6.86e-07	1.14e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—STAT3—asthma	6.86e-07	1.14e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—asthma	6.85e-07	1.14e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—asthma	6.85e-07	1.14e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—asthma	6.84e-07	1.14e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTT1—asthma	6.84e-07	1.14e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—asthma	6.77e-07	1.12e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—asthma	6.72e-07	1.12e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—EGFR—asthma	6.71e-07	1.11e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—asthma	6.68e-07	1.11e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPP2CA—asthma	6.67e-07	1.11e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PLA2G4A—asthma	6.6e-07	1.1e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTM1—asthma	6.6e-07	1.1e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—EGFR—asthma	6.59e-07	1.09e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—asthma	6.55e-07	1.09e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—asthma	6.53e-07	1.08e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—asthma	6.52e-07	1.08e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPP2CA—asthma	6.51e-07	1.08e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—asthma	6.51e-07	1.08e-05	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTEN—asthma	6.43e-07	1.07e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—asthma	6.38e-07	1.06e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—asthma	6.36e-07	1.06e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—EGFR—asthma	6.25e-07	1.04e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VEGFA—asthma	6.25e-07	1.04e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—EGFR—asthma	6.24e-07	1.04e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—asthma	6.2e-07	1.03e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—STAT3—asthma	6.18e-07	1.03e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—asthma	6.18e-07	1.03e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—asthma	6.17e-07	1.02e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PTEN—asthma	6.16e-07	1.02e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPP2CA—asthma	6.08e-07	1.01e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—asthma	5.95e-07	9.89e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—asthma	5.91e-07	9.81e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—asthma	5.74e-07	9.52e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—asthma	5.73e-07	9.52e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NQO1—asthma	5.68e-07	9.44e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—EGFR—asthma	5.62e-07	9.33e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—asthma	5.62e-07	9.33e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VEGFA—asthma	5.57e-07	9.24e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—asthma	5.56e-07	9.24e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ADCY2—asthma	5.56e-07	9.23e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—STAT3—asthma	5.51e-07	9.15e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—asthma	5.5e-07	9.13e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—asthma	5.4e-07	8.97e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—asthma	5.23e-07	8.68e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—asthma	5.16e-07	8.56e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—asthma	5.12e-07	8.5e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—asthma	5.11e-07	8.48e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—asthma	5.06e-07	8.41e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—EGFR—asthma	5.01e-07	8.32e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—asthma	5e-07	8.3e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—asthma	5e-07	8.3e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—asthma	4.81e-07	7.98e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—asthma	4.79e-07	7.96e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTP1—asthma	4.74e-07	7.87e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTEN—asthma	4.71e-07	7.82e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HMOX1—asthma	4.67e-07	7.76e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—asthma	4.67e-07	7.75e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—asthma	4.67e-07	7.75e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ITPR1—asthma	4.66e-07	7.74e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—asthma	4.61e-07	7.66e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—asthma	4.57e-07	7.6e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—asthma	4.56e-07	7.56e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—asthma	4.46e-07	7.41e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—asthma	4.36e-07	7.23e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PLA2G4A—asthma	4.36e-07	7.23e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTM1—asthma	4.36e-07	7.23e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—asthma	4.32e-07	7.17e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—asthma	4.26e-07	7.07e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—asthma	4.08e-07	6.78e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—asthma	4.07e-07	6.76e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPP2CA—asthma	4.01e-07	6.66e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTEN—asthma	3.99e-07	6.62e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—asthma	3.99e-07	6.62e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—asthma	3.85e-07	6.39e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—asthma	3.72e-07	6.18e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTEN—asthma	3.56e-07	5.91e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTEN—asthma	3.48e-07	5.77e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTEN—asthma	3.25e-07	5.39e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—asthma	3.08e-07	5.11e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—asthma	2.81e-07	4.66e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—asthma	2.68e-07	4.46e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—asthma	2.46e-07	4.08e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTEN—asthma	2.14e-07	3.56e-06	CbGpPWpGaD
